首页>Clinical lymphoma, myeloma & leukemia>Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
Patient Perceptions Regarding Ciltacabtagene Autoleucel Treatment: Qualitative Evidence From Interviews With Patients With Relapsed/Refractory Multiple Myeloma in the CARTITUDE-1 Study
作者单位:Icahn School of Medicine at Mount Sinai,Mt Sinai Med Ctr[1]Mem Sloan Canc Ctr[2]Janssen Res & Dev[3]Janssen Global Serv[4]Legend Biotech USA[5]RTI Hlth Solut[6]Myeloma Patients Europe[7]Univ Chicago[8]Mt Sinai Med Ctr[9]Med Coll Wisconsin[10]City Hope Comprehens Canc Ctr[11]